Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hualan Rabies Vaccine (Vero Cell) 4-Dose vs 5-Dose Regimen
NCT06177249Phase 3Completed
- Sponsor
- Hualan Biological Vaccine Inc.
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Purified Vero cell rabies vaccine in rabies (3 arms), sponsored by Hualan Biological Vaccine Inc. Primary endpoints: Local Adverse Reactions, Systemic Adverse Reactions and 1 more. Started Mar 2015; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT06177249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06177249.